600211 logo

Tibet Rhodiola Pharmaceutical Holding XSSC:600211 Stock Report

Last Price

CN¥37.24

Market Cap

CN¥12.0b

7D

-0.6%

1Y

-0.7%

Updated

22 Dec, 2024

Data

Company Financials +

Tibet Rhodiola Pharmaceutical Holding Co.

XSSC:600211 Stock Report

Market Cap: CN¥12.0b

My Notes

Capture your thoughts, links and company narrative

Tibet Rhodiola Pharmaceutical Holding Co. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tibet Rhodiola Pharmaceutical Holding
Historical stock prices
Current Share PriceCN¥37.24
52 Week HighCN¥45.12
52 Week LowCN¥26.95
Beta1.09
1 Month Change2.59%
3 Month Change16.67%
1 Year Change-0.65%
3 Year Change-2.67%
5 Year Changen/a
Change since IPO-24.38%

Recent News & Updates

Recent updates

Shareholder Returns

600211CN HealthcareCN Market
7D-0.6%-2.2%-1.2%
1Y-0.7%-7.7%11.8%

Return vs Industry: 600211 exceeded the CN Healthcare industry which returned -7.7% over the past year.

Return vs Market: 600211 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 600211's price volatile compared to industry and market?
600211 volatility
600211 Average Weekly Movement6.1%
Healthcare Industry Average Movement8.3%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 600211 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600211's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999601Yuan Dong Guowww.xzyy.cn

Tibet Rhodiola Pharmaceutical Holding Co. produces and sells pharmaceuticals in China and internationally. The company offers biological products, tibetan medicine, chinese medicine, and chemical medicine products. It also offers capsules, preparations, granules, and coatings for cardiovascular, cerebrovascular, hepatobiliary, sprains and contusions, rheumatism, rheumatoid arthritis, colds, etc. Tibet Rhodiola Pharmaceutical Holding Co. was founded in 1999 and is based in Lhasa, China.

Tibet Rhodiola Pharmaceutical Holding Co. Fundamentals Summary

How do Tibet Rhodiola Pharmaceutical Holding's earnings and revenue compare to its market cap?
600211 fundamental statistics
Market capCN¥12.00b
Earnings (TTM)CN¥737.44m
Revenue (TTM)CN¥2.94b

16.3x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600211 income statement (TTM)
RevenueCN¥2.94b
Cost of RevenueCN¥158.60m
Gross ProfitCN¥2.78b
Other ExpensesCN¥2.05b
EarningsCN¥737.44m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.29
Gross Margin94.61%
Net Profit Margin25.07%
Debt/Equity Ratio14.4%

How did 600211 perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

67%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 15:14
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tibet Rhodiola Pharmaceutical Holding Co. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Weina JiangEverbright Securities Co. Ltd.
Wen Liang CuiFounder Securities Co., Ltd.
Zhouyu DengGuosen Securities Co., Ltd.